T. Rowe Price Associates’s WebMD Health Corp. WBMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-513,763
Closed -$30.1M 2612
2017
Q2
$30.1M Buy
513,763
+14,059
+3% +$783K 0.01% 1020
2017
Q1
$26.3M Buy
499,704
+39,084
+8% +$2M ﹤0.01% 1051
2016
Q4
$22.8M Sell
460,620
-17,030
-4% -$880K ﹤0.01% 1094
2016
Q3
$23.7M Buy
477,650
+53,640
+13% +$2.96M ﹤0.01% 1073
2016
Q2
$24.6M Buy
424,010
+30,800
+8% +$1.93M 0.01% 1025
2016
Q1
$24.6M Buy
393,210
+5,540
+1% +$297K 0.01% 1013
2015
Q4
$18.7M Buy
387,670
+31,000
+9% +$1.38M ﹤0.01% 1103
2015
Q3
$14.2M Buy
356,670
+30,800
+9% +$1.3M ﹤0.01% 1210
2015
Q2
$14.4M Buy
325,870
+23,700
+8% +$1.08M ﹤0.01% 1245
2015
Q1
$13.2M Buy
302,170
+18,824
+7% +$782K ﹤0.01% 1253
2014
Q4
$11.2M Buy
283,346
+7,076
+3% +$272K ﹤0.01% 1296
2014
Q3
$11.6M Buy
276,270
+6,300
+2% +$304K ﹤0.01% 1269
2014
Q2
$13M Buy
269,970
+24,200
+10% +$1.06M ﹤0.01% 1253
2014
Q1
$10.2M Buy
245,770
+3,200
+1% +$144K ﹤0.01% 1299
2013
Q4
$9.58M Buy
242,570
+24,700
+11% +$891K ﹤0.01% 1294
2013
Q3
$6.23M Buy
217,870
+23,400
+12% +$730K ﹤0.01% 1385
2013
Q2
$5.71M Buy
+194,470
New +$5.2M ﹤0.01% 1381

Other funds holding WBMD

T. Rowe Price Associates's WBMD Position: Q3 2017 in Review

T. Rowe Price Associates sold out of WebMD Health Corp. (WBMD) in Q3 2017, closing a stake of 513,763 shares — an estimated $30.1M sold.

T. Rowe Price Associates first reported a position in WBMD in Q2 2013 and held it in 17 quarters. The position peaked at $30.1M in Q2 2017. 1 fund tracked by Wall St. Rank holds WBMD as of Q3 2017.

  • T. Rowe Price Associates reported no remaining WebMD Health Corp. position as of Q3 2017 after selling out during the quarter.
  • T. Rowe Price Associates sold 513,763 WebMD Health Corp. shares in Q3 2017, an estimated $30.1M.
  • T. Rowe Price Associates first reported a position in WebMD Health Corp. in Q2 2013 and held it in 17 quarters.
  • T. Rowe Price Associates's WebMD Health Corp. position peaked at $30.1M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held WebMD Health Corp. as of Q3 2017.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.